Leukotriene modulators as therapeutic agents in asthma and other inflammatory diseases

[11] CHABOTFLETCHER MC, 1995, J PHARMACOL EXP THER, V273, P1147

[12] CHAPMAN KR, 1995, AM J RESP CRIT CARE, V152, pA215

[13] CHAURET N, 1995, AM SOC PHARM EXP THE, V23, P1325

[14] ROLE OF LEUKOTRIENES REVEALED BY TARGETED DISRUPTION OF THE 5-LIPOXYGENASE GENE [J]. NATURE, 1994, 372 (6502) : 179 - 182

[15] COLLAWN C, 1992, AM J GASTROENTEROL, V87, P342

[16] CUTHBERT NJ, 1991, ANN NY ACAD SCI, V629, P402

[17] EFFECT OF THE LEUKOTRIENE RECEPTOR ANTAGONIST MK-0679 ON BASE-LINE PULMONARY-FUNCTION IN ASPIRIN-SENSITIVE ASTHMATIC SUBJECTS [J]. THORAX, 1993, 48 (12) : 1205 - 1210

[18] (E)-3-[6-[[(2,6-dichlorophenyl)thio]methyl]-3-(2-phenylethoxy)-2-pyridinyl]-2-propenoic acid: A high-affinity leukotriene B-4 receptor antagonist with oral antiinflammatory activity [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (19) : 3837 - 3841

[19] THE EFFECT OF MK-0591, A NOVEL 5-LIPOXYGENASE ACTIVATING PROTEIN INHIBITOR, ON LEUKOTRIENE BIOSYNTHESIS AND ALLERGEN-INDUCED AIRWAY RESPONSES IN ASTHMATIC SUBJECTS IN-VIVO [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1995, 95 (01) : 42 - 51

[20] DONNELLY A, 1993, J ALLERGY CLIN IMMUN, V91, P259

[11] CHABOTFLETCHER MC, 1995, J PHARMACOL EXP THER, V273, P1147

[12] CHAPMAN KR, 1995, AM J RESP CRIT CARE, V152, pA215

[13] CHAURET N, 1995, AM SOC PHARM EXP THE, V23, P1325

[14] ROLE OF LEUKOTRIENES REVEALED BY TARGETED DISRUPTION OF THE 5-LIPOXYGENASE GENE [J]. NATURE, 1994, 372 (6502) : 179 - 182

[15] COLLAWN C, 1992, AM J GASTROENTEROL, V87, P342

[16] CUTHBERT NJ, 1991, ANN NY ACAD SCI, V629, P402

[17] EFFECT OF THE LEUKOTRIENE RECEPTOR ANTAGONIST MK-0679 ON BASE-LINE PULMONARY-FUNCTION IN ASPIRIN-SENSITIVE ASTHMATIC SUBJECTS [J]. THORAX, 1993, 48 (12) : 1205 - 1210

[18] (E)-3-[6-[[(2,6-dichlorophenyl)thio]methyl]-3-(2-phenylethoxy)-2-pyridinyl]-2-propenoic acid: A high-affinity leukotriene B-4 receptor antagonist with oral antiinflammatory activity [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (19) : 3837 - 3841

[19] THE EFFECT OF MK-0591, A NOVEL 5-LIPOXYGENASE ACTIVATING PROTEIN INHIBITOR, ON LEUKOTRIENE BIOSYNTHESIS AND ALLERGEN-INDUCED AIRWAY RESPONSES IN ASTHMATIC SUBJECTS IN-VIVO [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1995, 95 (01) : 42 - 51

[20] DONNELLY A, 1993, J ALLERGY CLIN IMMUN, V91, P259